Cancer Research Summit 2025: Registration now open

SelectScience^® invites scientists and clinical researchers worldwide to the highly anticipated 2025 Cancer Research Summit – a free, interactive online event on January 30. Now in its fifth year, this event provides a unique platform for global cancer research professionals to connect, collaborate, and explore the latest advances in cancer and immunology research.

Registration is now open for this free-to-attend online conference that will feature cutting-edge presentations by industry-leading scientists, clinical researchers, and technology innovators.

By registering today, you will gain access to a host of expert-led talks on topics such as tumor microenvironment analysis, next-generation sequencing applications, cancer biomarker development, AI-driven drug discovery, and emerging precision medicine techniques.

Highlighted presentations include:

• Deciphering the complexities of the tumor microenvironment, one cell at a time – Dr. Arutha Kulasinghe, NHMRC Research Fellow and Clinical-oMx Group Leader, Frazer Institute, University of Queensland
• High-throughput automation in next-generation sequencing for the detection of minimum residual disease in liquid biopsies – Lubaina Kothari, Ontario Institute for Cancer Research
• Biomarkers in prostate cancer: Insights from discovery to clinical application – Dr. Nallasivam Palanisamy, Associate Scientist, Department of Urology, Henry Ford Health and Associate Professor of Research, Michigan State University
• AI-driven high-throughput drug screening on patient-derived tumor organoids: Accelerating precision medicine through novel mechanisms of action – Dr. Christophe Deben, Group Leader, Tumoroid Screening Lab, University of Antwerp and co-founder of Orbits Oncology
• Highplex imaging with the Orion platform for clinical trial testing – Dr. Richard Van Krieken, Senior Scientist, Navigate BioPharma Services
• Metabolomics in cancer research: Key findings - Dr. Julia Debik, Associate Professor, Dept. of Public Health and Nursing, Norwegian University of Science and Technology (NTNU)
• Screening of immune engager compounds using CRC patient-derived organoids (or “mini-organs”) and immune T cells subsets - Dr. Claudia Maria A. Pinna, Research Fellow and Lecturer, Department of Cancer and Genomic Sciences, University of Birmingham

With more excellent talks to be announced!

How to participate

Register in advance to receive detailed event access and program updates. Personalize your experience by bookmarking key presentations, which can be added directly to your calendar. On the day of the event, enter the virtual lobby (pictured below) and explore.

Why attend?

• Stay informed on breakthrough cancer research from world-class speakers
• Access a variety of resources, including whitepapers, posters, and case studies
• Engage in live Q&A sessions with scientists, researchers, and manufacturers
• Discover cutting-edge technologies in cancer research
• Expand your network with leading professionals across the globe

Register for free today so you don’t miss this opportunity to join a global gathering of cancer research experts.

For the latest news straight to your inbox, become a SelectScience member for free today.

For exhibit opportunities, manufacturers are encouraged to reach out to our sales team at salesteam@selectscience.net.